Rational design of drug-polymer co-formulations by CO2 anti-solvent precipitation

Journal of Supercritical Fluids

Volumn 48, Issue 2, 2009, Pages 176-182

  Kluge, Johannes ^a   Fusaro, Francesco ^a   Muhrer, Gerhard ^b   Thakur, Ranjit ^b   Mazzotti, Marco ^a  

^a ETH ZURICH   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Anti solvent; Class II drugs; Co formulation; Polymer; Precipitation; Supercritical

Indexed keywords

POLYMERS; SOLUBILITY; SOLVENTS; TERNARY SYSTEMS;

ANTI-SOLVENT; CLASS II DRUGS; CO-FORMULATION; PRECIPITATION; SUPERCRITICAL;

DRUG PRODUCTS;

EID: 63749089892     PISSN: 08968446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.supflu.2008.10.005     Document Type: Article

References (30)

1. Amidon G.L., Lennernas H., Shah V.P., and Crison J.R. A theoretical basis for a biopharmaceutic drug classification-the correlation of in-vitro drug product dissolution and in-vivo bioavailability. Pharmaceutical Research 12 3 (1995) 413-420
2. Leuner C., and Dressman J. Improving drug solubility for oral delivery using solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics 50 1 (2000) 47-60
3. Phillips E.M., and Stella V.J. Rapid expansion from supercritical solutions-application to pharmaceutical processes. International Journal of Pharmaceutics 94 1-3 (1993) 1-10
4. Subramaniam B., Rajewski R.A., and Snavely K. Pharmaceutical processing with supercritical carbon dioxide. Journal of Pharmaceutical Sciences 86 8 (1997) 885-890
5. Perrut M., Jung J., and Leboeuf F. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: micronization of neat particles. International Journal of Pharmaceutics 288 1 (2005) 3-10
6. Perrut M., Jung J., and Leboeuf F. Enhancement of dissolution rate of poorly soluble active ingredients by supercritical fluid processes. Part II: preparation of composite particles. International Journal of Pharmaceutics 288 1 (2005) 6-11
7. Yeo S.D., and Kiran E. Formation of polymer particles with supercritical fluids: a review. Journal of Supercritical Fluids 34 3 (2005) 287-308
8. Petersen R.C., Matson D.W., and Smith R.D. The formation of polymer fibers from the rapid expansion of supercritical fluid solutions. Polymer Engineering and Science 27 22 (1987) 1693-1697
9. Dixon D.J., Johnston K.P., and Bodmeier R.A. Polymeric materials formed by precipitation with a compressed fluid antisolvent. AIChE Journal 39 1 (1993) 127-139
10. Palakodaty S., and York P. Phase behavioral effects on particle formation processes using supercritical fluids. Pharmaceutical Research 16 7 (1999) 976-985
11. Debenedetti P.G., Tom J.W., Yeo S.D., and Lim G.B. Application of supercritical fluids for the production of sustained delivery devices. Journal of Controlled Release 24 1-3 (1993) 27-44
12. Ghaderi R., Artursson P., and Carlfors J. A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in DL-PLG microparticles using supercritical fluids. European Journal of Pharmaceutical Sciences 10 1 (2000) 1-9
13. Moneghini M., Kikic I., Voinovich D., Perissutti B., and Filipovic-Grcic J. Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterisation, and in vitro dissolution. International Journal of Pharmaceutics 222 1 (2001) 129-138
14. Charoenchaitrakool M., Dehghani F., and Foster N.R. Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-beta-cyclodextrin. International Journal of Pharmaceutics 239 1-2 (2002) 103-112
15. Perez de Diego Y., Pellikaan H.C., Wubbolts F.E., Witkamp G.J., and Jansens P.J. Operating regimes and mechanism of particle formation during the precipitation of polymers using the PCA process. Journal of Supercritical Fluids 35 2 (2005) 147-156
16. Moneghini M., Perissutti B., Kikic I., Grassi M., Cortesi A., and Princivalle F. Preparation of theophylline-hydroxypropylmethylcellulose matrices using supercritical antisolvent precipitation: a preliminary study. Drug Development and Industrial Pharmacy 32 1 (2006) 39-52
17. Franco M., Trapani G., Latrofa A., Tullio C., Provenzano M.R., Serra M., Muggironi M., Biggio G., and Liso G. Dissolution properties and anticonvulsant activity of phenytoin-polyethylene glycol 6000 and -polyvinylpyrrolidone K-30 solid dispersions. International Journal of Pharmaceutics 225 1-2 (2001) 63-73
18. Muhrer G., Meier U., Fusaro F., Albano S., and Mazzotti M. Use of compressed gas precipitation to enhance the dissolution behavior of a poorly water-soluble drug: generation of drug microparticles and drug-polymer solid dispersions. International Journal of Pharmaceutics 308 1-2 (2006) 69-83
19. Chow A.H.L., Gordon J.D., Szeitz A., and Young J.W.M. Modification of phenytoin crystals. 3. influence of 3-butanoyloxymethyl-5,5-diphenylhydantoin on solution-phase crystallization and related crystal properties. International Journal of Pharmaceutics 126 1-2 (1995) 11-19
20. Volker Bühler. Kollidon-Polyvinylpyrrolidone for the Pharmaceutical Industry, 7th edition, BASF Aktiengesellschaft, Pharma Ingredients, 67056 Ludwigshafen, Germany, 2003.
21. Konno H., and Taylor L.S. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. Journal of Pharmaceutical Sciences 95 12 (2006) 2692-2705
22. Marsac P.J., Shamblin S.L., and Taylor L.S. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharmaceutical Research 23 10 (2006) 2417-2426
23. Sarti G.C., and Doghieri F. Predictions of the solubility of gases in glassy polymers based on the NELF model. Chemical Engineering Science 53 19 (1998) 3435-3447
24. Vasanthavada M., Tong W.Q., Joshi Y., and Kislalioglu M.S. Phase behavior of amorphous molecular dispersions I: determination of the degree and mechanism of solid solubility. Pharmaceutical Research 21 9 (2004) 1598-1606
25. Vasanthavada M., Tong W.Q., Joshi Y., and Kislalioglu M.S. Phase behavior of amorphous molecular dispersions II: role of hydrogen bonding in solid solubility and phase separation kinetics. Pharmaceutical Research 22 3 (2005) 440-448
26. Marsac P.J., Konno H., and Taylor L.S. A comparison of the physical stability of amorphous felodipine and nifedipine systems. Pharmaceutical Research 23 10 (2006) 2306-2316
27. Rodier E., Lochard H., Sauceau M., Letourneau J.J., Freiss B., and Fages J. A three step supercritical process to improve the dissolution rate of eflucimibe. European Journal of Pharmaceutical Sciences 26 2 (2005) 184-193
28. Reverchon E., and De Marco I. Supercritical fluid extraction and fractionation of natural matter. Journal of Supercritical Fluids 38 2 (2006) 146-166
29. Six K., Leuner C., Dressman J., Verreck G., Peeters J., Blaton N., Augustijns P., Kinget R., and Van den Mooter G. Thermal properties of hot-stage extrudates of itraconazole and eudragit E100-phase separation and polymorphism. Journal of Thermal Analysis and Calorimetry 68 2 (2002) 591-601
30. Tanno F., Nishiyama Y., Kokubo H., and Obara S. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions. Drug Development and Industrial Pharmacy 30 1 (2004) 9-17